0.2525
price up icon30.15%   0.0585
pre-market  Pre-mercato:  .34   0.0875   +34.65%
loading
Precedente Chiudi:
$0.194
Aprire:
$0.2059
Volume 24 ore:
19.40M
Relative Volume:
2.16
Capitalizzazione di mercato:
$10.83M
Reddito:
-
Utile/perdita netta:
$-22.71M
Rapporto P/E:
-0.0216
EPS:
-11.71
Flusso di cassa netto:
$-18.24M
1 W Prestazione:
+24.81%
1M Prestazione:
-13.44%
6M Prestazione:
-4.54%
1 anno Prestazione:
-26.13%
Intervallo 1D:
Value
$0.2001
$0.259
Intervallo di 1 settimana:
Value
$0.17
$0.28
Portata 52W:
Value
$0.14
$3.97

Genprex Inc Stock (GNPX) Company Profile

Name
Nome
Genprex Inc
Name
Telefono
512-537-7997
Name
Indirizzo
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Name
Dipendente
15
Name
Cinguettio
@genprex
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
GNPX's Discussions on Twitter

Confronta GNPX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GNPX
Genprex Inc
0.2525 8.32M 0 -22.71M -18.24M -11.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Genprex Inc Stock (GNPX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-01-26 Iniziato National Securities Buy
2019-04-29 Iniziato Noble Capital Markets Outperform

Genprex Inc Borsa (GNPX) Ultime notizie

pulisher
Oct 14, 2025

What institutional flow reveals about Genprex Inc.Weekly Trade Review & High Win Rate Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Pre-market Movers: GNPX, BFRI, DBVT See Big Swings - RTTNews

Oct 14, 2025
pulisher
Oct 14, 2025

Why Genprex Inc. stock is popular among millennials2025 Price Momentum & AI Enhanced Trading Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

10–33x tumor uptake: Genprex's REQORSA shows targeted TUSC2 delivery in preclinical poster on Oct 25 - Stock Titan

Oct 14, 2025
pulisher
Oct 14, 2025

Using portfolio simulators with Genprex Inc. includedMarket Risk Summary & Technical Buy Zone Confirmations - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Genprex Inc. stock responds to policy changesMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Will Genprex Inc. stock deliver consistent dividendsWeekly Trend Summary & Community Supported Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to forecast Genprex Inc. trends using time seriesPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com

Oct 13, 2025
pulisher
Oct 09, 2025

Heatmap analysis for Genprex Inc. and competitorsJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What to expect from Genprex Inc. in the next 30 daysJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Genprex Inc. still worth holding after the dipQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

How high can Genprex Inc. stock goMarket Movers & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Genprex Inc. stock resist market sell offsJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Genprex Inc. (2DE0) stock a top hedge fund pickTrade Entry Report & High Conviction Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Analyzing net buyer seller activity in Genprex Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Risk vs reward if holding onto Genprex Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - FinancialContent

Sep 30, 2025
pulisher
Sep 30, 2025

Is Genprex Inc a good long term investmentDividend Stock Watch & Superior Wealth Strategies - earlytimes.in

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Genprex Inc stockRetail Investor Activity & Invest Now – Opportunity Window Closing - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What drives Genprex Inc 2DE0 stock priceIPO Market Watch & Claim Your Custom Stock Report Now - earlytimes.in

Sep 27, 2025
pulisher
Sep 27, 2025

Using economic indicators to assess Genprex Inc. potentialEarnings Recap Report & Low Risk Entry Point Tips - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Genprex Inc stock priceTechnical Breakout Signals & Free Trading Signals to Sharpen Your Edge - Early Times

Sep 27, 2025
pulisher
Sep 20, 2025

What the charts say about Genprex Inc. today2025 Technical Overview & Reliable Volume Spike Alerts - newser.com

Sep 20, 2025

Genprex Inc Azioni (GNPX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Capitalizzazione:     |  Volume (24 ore):